The harrowing, hope-filled childhood of author Trent Dalton is now a major Netflix series. Discover the incredible true story of drug lords, a mute magician, and a mother's fight for redemption that inspired a literary phenomenon.
A new oral weight loss drug, Orforglipron, shows staggering results in a major clinical trial, offering a powerful and convenient alternative to injectable treatments for obesity.
Major pharmaceutical giants AstraZeneca, MSD (Merck), and Eli Lilly announce massive new investments in UK research and manufacturing, signalling a major vote of confidence in the British life sciences sector following the US election result.
Ariana Grande is officially dating her Wicked film co-star, Ethan Slater. The news comes just as the Broadway actor has separated from his wife of several years, Lilly Jay, with whom he shares a young child. The whirlwind romance has blossomed on the set
Exclusive insight into the cryptic comments and social media activity from Ariana Grande and Ethan Slater that have set the rumour mill into overdrive, suggesting trouble in paradise for the 'Wicked' co-stars.
In a significant setback for British research, pharmaceutical titan Eli Lilly is closing its London research and development hub, putting over 100 jobs at risk and raising concerns about the UK's post-Brexit scientific competitiveness.
Exclusive: Diabetes and weight loss patients face financial strain as Eli Lilly's new Mounjaro KwikPens hit the market without the anticipated price reduction, maintaining a premium cost for the identical medication.
Danish pharmaceutical giant Novo Nordisk announces major restructuring, cutting 9,000 jobs globally. The move comes as competition intensifies in the lucrative weight-loss and diabetes drug market, challenging its blockbuster medications Ozempic and Wegov
Exclusive: Pop sensation Ariana Grande and her 'Wicked' co-star Ethan Slater have called it quits. Insiders reveal the 'rose curse' TikTok trend, the VMAs no-show, and the real reasons behind their sudden breakup, just weeks after their controversial roma
Eli Lilly deals a major blow to UK Mounjaro users, announcing a smaller KwikPen, the removal of a key 12.5mg dose, and a staggering 170% price increase, sparking outrage and access fears.
Exclusive: Desperate UK diabetics face a devastating health crisis as they are cut off from the 'miracle' weight-loss drug Mounjaro (tirzepatide) due to soaring costs and an NHS postcode lottery, with patients fearing for their lives.
A groundbreaking new weight loss pill from Eli Lilly, orforglipron, has demonstrated remarkable results in a UK trial, offering a potential oral alternative to injectable treatments like Mounjaro for combating obesity.
A new oral weight loss medication, Orforglipron, shows transformative potential in UK clinical trials, matching the efficacy of injectable treatments like Mounjaro and offering new hope for tackling obesity.
Disney+ has pulled the plug on the highly anticipated 'Chad Powers' series, starring Glen Powell, in a major strategic U-turn that has stunned the industry and left fans reeling.
Atomic Kitten star Kerry Katona gets emotional on her podcast, revealing the deep pain of being cut off by two of her daughters and her fears of history repeating itself.
Virgin Radio DJ Chris Evans offers a heartfelt update on his 13-year-old son Eli's recovery from a major operation, sharing a rare and touching family photo from the hospital.
Eli Lilly drastically cuts the price of its Mounjaro injection in the UK, making the revolutionary diabetes and weight loss treatment more accessible. The move follows a landmark NHS supply deal.
The MHRA has officially approved the weight-loss injection Mounjaro (tirzepatide) for the UK market, with a set price, marking a significant new option in the nation's battle against obesity.
Exclusive: A perfect storm of NHS price hikes and soaring demand for the 'miracle' drug tirzepatide triggers a national shortage, leaving thousands of diabetics and weight-loss patients in limbo. Fears grow as stockpiling begins.
The weight loss drug Mounjaro (tirzepatide) is launching in the UK, challenging Ozempic. Experts warn of potential shortages and urge prescriptions for those with clinical need, not casual use.
The UK's medicines watchdog approves the weight loss injection Mounjaro (tirzepatide), offering a powerful new option in the fight against obesity. Discover its price, how it works, and where to get it.
Eli Lilly suspends shipments of obesity drug Mounjaro to the UK, triggering a major price surge and leaving thousands of patients in limbo amid supply chain restructuring.
A groundbreaking oral weight loss drug, Orforglipron, has demonstrated dramatic results in a recent clinical trial, offering a potential pill-based alternative to popular injectable treatments like Wegovy. The study shows significant weight reduction, spa
In a seismic shift for media, Time Out Magazine abandons its London birthplace after 55 years, relocating its global headquarters to Manhattan. Discover the reasons behind this historic move.
Breakthrough UK study reveals Retatrutide, the new triple-action 'Godzilla' weight loss injection, is dramatically more effective than its predecessors, helping patients lose up to 24% of their body weight in just 48 weeks.
UK health officials issue a critical safety alert for the type 2 diabetes drug Mounjaro (tirzepatide), linking it to severe stomach paralysis and intestinal blockages. Patients are urged to recognise the warning signs.
An in-depth look at how the celebrity lifestyles of Katie Price and Kerry Katona have profoundly impacted their daughters, Princess Andre and Lilly-Sue, leading to cosmetic surgery, broken marriages, and public struggles.
Atomic Kitten star Kerry Katona gets emotional on podcast, revealing the deep pain of being cut off by two of her daughters and her fears of history repeating itself.
The cost of diabetes and weight-loss drugs Mounjaro and Ozempic has surged, sparking concerns over affordability and market competition. Experts weigh in on the implications.
Pharmaceutical giant Eli Lilly announces a significant price increase for its diabetes and weight-loss drug Mounjaro in the UK, sparking concerns over affordability and access.